Market research
LMNX Defiance Daily Target 2x Long LMND ETF
NASDAQ USD Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 2B
- P/E ratio
- 73.83
- Analyst target
- 37
- Dividend yield
- 1.0%
- Beta
- 0.0
Profile
Company facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- ISIN
- US55027E1029
- Market cap
- 2B
- P/E ratio
- 73.83
- Analyst target
- 37
- Dividend yield
- 1.0%
- Beta
- 0.0
About
About Defiance Daily Target 2x Long LMND ETF
The fund is an actively managed exchange traded fund ("ETF") that attempts to achieve two times (200%) the daily percentage change in the share price of the Underlying Security by employing derivatives, namely swap agreements and/or listed options contracts. The fund manager has adopted a policy to have at least 80% exposure to financial instruments with economic characteristics that should perform 2X the daily performance of the Underlying Security"s shares. The fund is non-diversified.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the LMNX discussion.
5 years, 4 months ago
Luminex Corporation is currently in a long term uptrend where the price is trading 23.2% above its 200 day moving average.
From a valuation standpoint, the stock is 99.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.5.
Luminex Corporation's total revenue rose by 23.1% to $111M since the same quarter in the previous year.
Its net income has dropped by 92.9% to $239K since the same quarter in the previous year.
Finally, its free cash flow grew by 116.9% to $5M since the same quarter in the previous year.
Based on the above factors, Luminex Corporation gets an overall score of 4/5.